Pfizer shows Europe how it’s done, now all eyes turn to Roche
Pfizer, the US drugs firm, secured a $22.5bn loan this week, a deal which will likely hit European borrowers looking for similarly sized facilities.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
